Lindonlight Collective’s Post

Lindonlight Collective reposted this

Daiichi Sankyo is deeply saddened by the passing of Dr. Toshinori Agatsuma, Executive Officer, Head of Research, Daiichi Sankyo, who passed away on December 5, 2024. A true scientific innovator in every sense of the word, Dr. Agatsuma leaves an immeasurable legacy on the global oncology community as a pioneer of hope for countless people impacted by cancer. His patience, scientific expertise and compassionate leadership altered the trajectory of Daiichi Sankyo into a company with competitive advantage in oncology.     We invite you to learn more about the life and legacy Dr. Agatsuma and the profound impact he had on patients around the world. Company website statement: https://bit.ly/3ZrhDN0 Pursuing Anticancer Drug Possibilities: https://bit.ly/3ZFVo7e  Dr. Agatsuma’s Story: https://bit.ly/4ghBODO   Q&A on Japan Bioindustry Award: https://bit.ly/4fWJ4FB     Dr. Agatsuma's pursuit to transform science into medicine has helped make the world a better place and will benefit the patients of today, tomorrow and beyond. We send our deepest condolences to his family. 

  • Daiichi Sankyo is deeply saddened by the passing of Dr. Toshinori Agatsuma, Executive Officer, Head of Research, Daiichi Sankyo who passed away on December 5, 2024. A true scientific innovator in every sense of the word, Dr. Agatsuma leaves an immeasurable legacy on the global oncology community as a pioneer of hope for countless people impacted by cancer. His patience, scientific expertise and compassionate leadership altered the trajectory of Daiichi Sankyo into a company with competitive advantage in oncology.

To view or add a comment, sign in

Explore topics